Skip to main content

Table 1 Definition of patients in each subgroup

From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Subgroup Patient characteristics
Group 1 Normal weight patients without HBV infection
Group 2 Normal weight patients combined HBV infection
Group 3 Overweight patients without HBV infection
Group 4 Overweight patients combined HBV infection